Table of Contents

2019-2024 Global Mitomycin C Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Mitomycin C Consumption 2014-2024
  • 2.1.2 Mitomycin C Consumption CAGR by Region
• 2.2 Mitomycin C Segment by Type
  • 2.2.1 2 Mg
  • 2.2.2 10 Mg
  • 2.2.3 40 Mg
  • 2.2.4 Other
• 2.3 Mitomycin C Consumption by Type
  • 2.3.1 Global Mitomycin C Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Mitomycin C Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Mitomycin C Sale Price by Type (2014-2019)
• 2.4 Mitomycin C Segment by Application
  • 2.4.1 Cancer Treatment
  • 2.4.2 Ophthalmic Use
  • 2.4.3 Others
• 2.5 Mitomycin C Consumption by Application
  • 2.5.1 Global Mitomycin C Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Mitomycin C Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Mitomycin C Sale Price by Application (2014-2019)

3 Global Mitomycin C by Players

• 3.1 Global Mitomycin C Sales Market Share by Players
  • 3.1.1 Global Mitomycin C Sales by Players (2017-2019)
  • 3.1.2 Global Mitomycin C Sales Market Share by Players (2017-2019)
• 3.2 Global Mitomycin C Revenue Market Share by Players
  • 3.2.1 Global Mitomycin C Revenue by Players (2017-2019)
  • 3.2.2 Global Mitomycin C Revenue Market Share by Players (2017-2019)
• 3.3 Global Mitomycin C Sale Price by Players
• 3.4 Global Mitomycin C Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Mitomycin C Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Mitomycin C Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Mitomycin C by Regions

• 4.1 Mitomycin C by Regions
  • 4.1.1 Global Mitomycin C Consumption by Regions
  • 4.1.2 Global Mitomycin C Value by Regions
• 4.2 Americas Mitomycin C Consumption Growth
• 4.3 APAC Mitomycin C Consumption Growth
• 4.4 Europe Mitomycin C Consumption Growth
• 4.5 Middle East & Africa Mitomycin C Consumption Growth

5 Americas

• 5.1 Americas Mitomycin C Consumption by Countries
  • 5.1.1 Americas Mitomycin C Consumption by Countries (2014-2019)
  • 5.1.2 Americas Mitomycin C Value by Countries (2014-2019)
• 5.2 Americas Mitomycin C Consumption by Type
• 5.3 Americas Mitomycin C Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Mitomycin C Consumption by Countries
  • 6.1.1 APAC Mitomycin C Consumption by Countries (2014-2019)
  • 6.1.2 APAC Mitomycin C Value by Countries (2014-2019)
• 6.2 APAC Mitomycin C Consumption by Type
• 6.3 APAC Mitomycin C Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Mitomycin C by Countries
  • 7.1.1 Europe Mitomycin C Consumption by Countries (2014-2019)
  • 7.1.2 Europe Mitomycin C Value by Countries (2014-2019)
• 7.2 Europe Mitomycin C Consumption by Type
• 7.3 Europe Mitomycin C Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Mitomycin C by Countries
  • 8.1.1 Middle East & Africa Mitomycin C Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Mitomycin C Value by Countries (2014-2019)
• 8.2 Middle East & Africa Mitomycin C Consumption by Type
• 8.3 Middle East & Africa Mitomycin C Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Mitomycin C Distributors
• 10.3 Mitomycin C Customer

11 Global Mitomycin C Market Forecast

• 11.1 Global Mitomycin C Consumption Forecast (2019-2024)
• 11.2 Global Mitomycin C Forecast by Regions
  • 11.2.1 Global Mitomycin C Forecast by Regions (2019-2024)
  • 11.2.2 Global Mitomycin C Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Mitomycin C Forecast by Type
• 11.8 Global Mitomycin C Forecast by Application

12 Key Players Analysis

• 12.1 Kyowa-kirin
  • 12.1.1 Company Details
  • 12.1.2 Mitomycin C Product Offered
  • 12.1.3 Kyowa-kirin Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Kyowa-kirin News
• 12.2 Intas Pharmaceuticals
  • 12.2.1 Company Details
  • 12.2.2 Mitomycin C Product Offered
  • 12.2.3 Intas Pharmaceuticals Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Intas Pharmaceuticals News
• 12.3 Teva
  • 12.3.1 Company Details
  • 12.3.2 Mitomycin C Product Offered
  • 12.3.3 Teva Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Teva News
• 12.4 Bristol-Myers Squibb
  • 12.4.1 Company Details
  • 12.4.2 Mitomycin C Product Offered
  • 12.4.3 Bristol-Myers Squibb Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Bristol-Myers Squibb News
• 12.5 Aspen
  • 12.5.1 Company Details
  • 12.5.2 Mitomycin C Product Offered
  • 12.5.3 Aspen Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Aspen News
• 12.6 Speciality European Pharma
  • 12.6.1 Company Details
  • 12.6.2 Mitomycin C Product Offered
  • 12.6.3 Speciality European Pharma Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Speciality European Pharma News
• 12.7 Alkem Laboratories
  • 12.7.1 Company Details
  • 12.7.2 Mitomycin C Product Offered
  • 12.7.3 Alkem Laboratories Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Alkem Laboratories News
• 12.8 Varifarma
  • 12.8.1 Company Details
  • 12.8.2 Mitomycin C Product Offered
  • 12.8.3 Varifarma Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Varifarma News
• 12.9 APOGEPHA
  • 12.9.1 Company Details
  • 12.9.2 Mitomycin C Product Offered
  • 12.9.3 APOGEPHA Mitomycin C Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 APOGEPHA News

13 Research Findings and Conclusion

Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).
In the last several years, Global market of Mitomycin C was experienced an upward trend rapidly, with an average growth rate of 4.76%. In 2016, Global Revenue of Mitomycin C is nearly 119.83 M USD; the actual production is about 17370 K Unit.

The global average price of Mitomycin C is in the increasing trend, from 6.30 USD/Unit in 2012 to 6.90 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.

The classification of Mitomycin C includes 2 Mg, 10 Mg, 40 Mg, and others. The proportion of 2 Mg in 2016 is about 41.5%, and the proportion is in decreasing trend from 2012 to 2016.

Mitomycin C is widely used in Cancer Treatment, Ophthalmic Use, and other field. The most proportion of Mitomycin C is Cancer Treatment, and the proportion in 2016 is 69%. The trend of Cancer Treatment is decreasing.

Japan is the largest supplier of Mitomycin C, with a production market share nearly 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, enjoying production market share nearly 25% in 2016.

North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32.6%.

Market competition is not intense. Kyowa-kirin, Intas Pharmaceuticals, Teva, Bristol-Myers Squibb, Aspen, Speciality European Pharma, etc. are the leaders of the industry.

According to this study, over the next five years the Mitomycin C market will register a -2.3% CAGR in terms of revenue, the global market size will reach US$ 100 million by 2024, from US$ 120 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Mitomycin C business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Mitomycin C market by product type, application, key manufacturers and key regions and countries.

This study considers the Mitomycin C value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
2 Mg
10 Mg
40 Mg
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer Treatment
Ophthalmic Use
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Kyowa-kirin
Intas Pharmaceuticals
Teva
Bristol-Myers Squibb
Aspen
Speciality European Pharma
Alkem Laboratories
Varifarma
APOGEPHA

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Mitomycin C consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Mitomycin C market by identifying its various subsegments.
Focuses on the key global Mitomycin C manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Mitomycin C with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Mitomycin C submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.